Skip to main content
Erschienen in: Archives of Dermatological Research 2/2010

01.03.2010 | Original Paper

Lymphocyte subsets in peripheral blood of patients with psoriasis before and after treatment with leishmania antigens

verfasst von: Jose Antonio O’Daly, Beatriz Rodriguez, Tania Ovalles, Civel Pelaez

Erschienen in: Archives of Dermatological Research | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Peripheral blood mononuclear cells (PBMC) collected from subjects prior to treatment and post-treatment with a vaccine composed of leishmania antigens were analyzed by flow cytometry. Upon analysis, it was noticed that lymphocyte subsets (LS) varied with psoriasis area and severity index (PASI) range (1–10, 11–20 and 21–72). Pre-treatment absolute values of gated LS were as follows. CD4+CD8−, CD3+CD8−, CD8+CD3+, CD8+CD4− and CD8+HLA− decreased in PBMC as PASI increased, suggesting migration from the blood to the skin. Contrary to the previous finding, the following LS, CD8+HLA+ and HLA+CD8−, and membrane surface immunoglobulin IgA+, IgD+ and IgM+ increased in PBMC as PASI increased, suggesting activation and proliferation by unknown antigens. After treatment with seven doses of AS100, the following LS, CD3+CD8−, CD8+CD3−, HLA+CD8−, CD8+HLA+ and CD4+CD8−, increased, while CD8+CD3+, CD8+HLA−, CD19 and CD8+CD4+ decreased in PBMC.
Literatur
1.
Zurück zum Zitat Abul H, Mahmoud F, Al Saleh Q et al (2002) Profiles of activated T lymphocytes in peripheral blood of Kuwaiti psoriasis vulgaris patients. J Dermatol 29:202–208PubMed Abul H, Mahmoud F, Al Saleh Q et al (2002) Profiles of activated T lymphocytes in peripheral blood of Kuwaiti psoriasis vulgaris patients. J Dermatol 29:202–208PubMed
2.
Zurück zum Zitat Bachelez H (2005) Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunity. J Autoimmun 25:69–73CrossRefPubMed Bachelez H (2005) Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunity. J Autoimmun 25:69–73CrossRefPubMed
3.
Zurück zum Zitat Baker BS, Swain AF, Valdimarsson H et al (1984) T-cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol 110:37–44CrossRefPubMed Baker BS, Swain AF, Valdimarsson H et al (1984) T-cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol 110:37–44CrossRefPubMed
4.
Zurück zum Zitat Blue ML, Daley JF, Levine H et al (1985) Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol 134:2281–2286PubMed Blue ML, Daley JF, Levine H et al (1985) Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol 134:2281–2286PubMed
5.
Zurück zum Zitat Bock O, Kreiselmeyer I, Mrowietz U (2001) Expression of dipeptidyl-peptidase IV (CD26) on CD8+ T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis. Exp Dermatol 10:414–419CrossRefPubMed Bock O, Kreiselmeyer I, Mrowietz U (2001) Expression of dipeptidyl-peptidase IV (CD26) on CD8+ T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis. Exp Dermatol 10:414–419CrossRefPubMed
6.
Zurück zum Zitat Christophers E, Mrowietz U (2003) Psoriasis. In: Freedberg IM, Eisen AZ, Wolff KK, Austen F, Goldsmith LA, Si Katz (eds) Fitzpatrick’s dermatology in general medicine, 6th edn. McGraw-Hill, New York, pp 407–427 Christophers E, Mrowietz U (2003) Psoriasis. In: Freedberg IM, Eisen AZ, Wolff KK, Austen F, Goldsmith LA, Si Katz (eds) Fitzpatrick’s dermatology in general medicine, 6th edn. McGraw-Hill, New York, pp 407–427
7.
Zurück zum Zitat Endharti AT, Rifa’ IM, Shi Z et al (2005) Cutting Edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-γ production and proliferation of CD8+ T cells. J Immunol 175:7093–7097PubMed Endharti AT, Rifa’ IM, Shi Z et al (2005) Cutting Edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-γ production and proliferation of CD8+ T cells. J Immunol 175:7093–7097PubMed
8.
Zurück zum Zitat Gudjonsson JE, Johnston A, Sigmundsdottir H et al (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1–8CrossRefPubMed Gudjonsson JE, Johnston A, Sigmundsdottir H et al (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1–8CrossRefPubMed
9.
Zurück zum Zitat Huang X, Yang Y (2006) The fate of effector CD8 T cells in vivo is controlled by the duration of antigen stimulation. Immunology 118:361–371CrossRefPubMed Huang X, Yang Y (2006) The fate of effector CD8 T cells in vivo is controlled by the duration of antigen stimulation. Immunology 118:361–371CrossRefPubMed
10.
Zurück zum Zitat Kemp M, Hansen MB, Theander TG (1992) Recognition of leishmaniaantigens by T lymphocytes from nonexposed individuals. Infect Immun 60:2246–2251PubMed Kemp M, Hansen MB, Theander TG (1992) Recognition of leishmaniaantigens by T lymphocytes from nonexposed individuals. Infect Immun 60:2246–2251PubMed
11.
Zurück zum Zitat Kitchen SG, Whitmire JK, Jones NR et al (2005) The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens. Proc Natl Acad Sci USA 102:3794–3799CrossRefPubMed Kitchen SG, Whitmire JK, Jones NR et al (2005) The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens. Proc Natl Acad Sci USA 102:3794–3799CrossRefPubMed
12.
Zurück zum Zitat Koch HJ, Wollina U, Seyfarth M et al (1990) Detection of IgA in diseased skin and serum of patients with psoriasis vulgaris. Dermatol Monatsschr 176:225–231PubMed Koch HJ, Wollina U, Seyfarth M et al (1990) Detection of IgA in diseased skin and serum of patients with psoriasis vulgaris. Dermatol Monatsschr 176:225–231PubMed
13.
Zurück zum Zitat Krueger JG, Bowcock A (2005) Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 64(Suppl 2):ii30–ii36CrossRefPubMed Krueger JG, Bowcock A (2005) Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 64(Suppl 2):ii30–ii36CrossRefPubMed
14.
Zurück zum Zitat Langewouters AMG, van Erp PEJ, de Jong EMGJ et al (2008) Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis. Arch Dermatol Res 300:107–113CrossRefPubMed Langewouters AMG, van Erp PEJ, de Jong EMGJ et al (2008) Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis. Arch Dermatol Res 300:107–113CrossRefPubMed
15.
Zurück zum Zitat Laux I, Khoshnan A, Tindell C et al (2000) Response differences between human CD4+ and CD8+ T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging. Clin Immunol 96:187–197CrossRefPubMed Laux I, Khoshnan A, Tindell C et al (2000) Response differences between human CD4+ and CD8+ T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging. Clin Immunol 96:187–197CrossRefPubMed
16.
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193(1):265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193(1):265–275PubMed
17.
Zurück zum Zitat Nair RP, Ding J, Duffin KC et al (2009) Psoriasis bench to bedside. Arch Dermatol 145:462–464CrossRefPubMed Nair RP, Ding J, Duffin KC et al (2009) Psoriasis bench to bedside. Arch Dermatol 145:462–464CrossRefPubMed
18.
Zurück zum Zitat Nickoloff BJ, Nestle FO (2004) Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113:1664–1675PubMed Nickoloff BJ, Nestle FO (2004) Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113:1664–1675PubMed
19.
Zurück zum Zitat O’Daly JA, Lezama R, Gleason J (2009) Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis. Arch Dermatol Res 301:411–427CrossRefPubMed O’Daly JA, Lezama R, Gleason J (2009) Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis. Arch Dermatol Res 301:411–427CrossRefPubMed
20.
Zurück zum Zitat O’Daly JA, Lezama R, Rodriguez PJ et al (2009) Antigens from Leishmania amastigotes induced clinical remission of psoriasis. Arch Dermatol Res 301:1–13CrossRefPubMed O’Daly JA, Lezama R, Rodriguez PJ et al (2009) Antigens from Leishmania amastigotes induced clinical remission of psoriasis. Arch Dermatol Res 301:1–13CrossRefPubMed
21.
Zurück zum Zitat O’Daly JA, Rodriguez MB (1988) Differential growth requirements of several leishmania spp in chemically defined culture media. Acta Trop Basel 45:109–126PubMed O’Daly JA, Rodriguez MB (1988) Differential growth requirements of several leishmania spp in chemically defined culture media. Acta Trop Basel 45:109–126PubMed
22.
Zurück zum Zitat Ozturk G, Erbas D, Gelir E et al (2001) Natural killer cell activity, serum immunoglobulins, complement proteins, and zinc levels in patients with psoriasis vulgaris. Immunol Invest 30:181–190CrossRefPubMed Ozturk G, Erbas D, Gelir E et al (2001) Natural killer cell activity, serum immunoglobulins, complement proteins, and zinc levels in patients with psoriasis vulgaris. Immunol Invest 30:181–190CrossRefPubMed
23.
Zurück zum Zitat Prinz JC, Vollmer S, Boehncke WH et al (1999) Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur J Immunol 29:3360–3368CrossRefPubMed Prinz JC, Vollmer S, Boehncke WH et al (1999) Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur J Immunol 29:3360–3368CrossRefPubMed
24.
Zurück zum Zitat Rantakokko K, Rimpilainen M, Uksila J et al (1997) Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol 15:399–404PubMed Rantakokko K, Rimpilainen M, Uksila J et al (1997) Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol 15:399–404PubMed
25.
Zurück zum Zitat Reibke R, Garbi N, Ganss R et al (2006) CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen. Proc Natl Acad Sci USA 103:15142–15147CrossRefPubMed Reibke R, Garbi N, Ganss R et al (2006) CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen. Proc Natl Acad Sci USA 103:15142–15147CrossRefPubMed
26.
Zurück zum Zitat Sabat R, Philipp S, Hoflich C et al (2007) Immunopathogenesis of psoriasis. Exp Dermatol 16:779–798CrossRefPubMed Sabat R, Philipp S, Hoflich C et al (2007) Immunopathogenesis of psoriasis. Exp Dermatol 16:779–798CrossRefPubMed
27.
Zurück zum Zitat Sala P, Tonutti E, Feruglio C et al (1993) Persistent expansions of CD4+ CD8+ peripheral blood T cells. Blood 82:1546–1552PubMed Sala P, Tonutti E, Feruglio C et al (1993) Persistent expansions of CD4+ CD8+ peripheral blood T cells. Blood 82:1546–1552PubMed
28.
Zurück zum Zitat Sigmundsdottir H, Gudjonsson JE, Jonsdottir I et al (2001) The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 126:365–369CrossRefPubMed Sigmundsdottir H, Gudjonsson JE, Jonsdottir I et al (2001) The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 126:365–369CrossRefPubMed
29.
Zurück zum Zitat Simelyte E, Rimpilainen M, Zhang X et al (2003) Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis. Ann Rheum Dis 62:976–982CrossRefPubMed Simelyte E, Rimpilainen M, Zhang X et al (2003) Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis. Ann Rheum Dis 62:976–982CrossRefPubMed
30.
Zurück zum Zitat Smith PK, Krohn RI, Hermanson GT et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85CrossRefPubMed Smith PK, Krohn RI, Hermanson GT et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85CrossRefPubMed
31.
Zurück zum Zitat Trautmann A, Rückert B, Schmid-Grendelmeier P (2003) Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation. Immunology 108:305–312CrossRefPubMed Trautmann A, Rückert B, Schmid-Grendelmeier P (2003) Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation. Immunology 108:305–312CrossRefPubMed
32.
Zurück zum Zitat Van Lingen RG, van de Kerkhof PCM, de Jong EMGJ et al (2008) Reduced CD26bright expression of peripheral blood CD8+ T-cell subsets in psoriatic patients. Exp Dermatol 17:343–348CrossRefPubMed Van Lingen RG, van de Kerkhof PCM, de Jong EMGJ et al (2008) Reduced CD26bright expression of peripheral blood CD8+ T-cell subsets in psoriatic patients. Exp Dermatol 17:343–348CrossRefPubMed
33.
Zurück zum Zitat Wu Y, Zheng Z, Jiang Y et al (2009) The specificity of T cell regulation that enables self-nonself discrimination in the periphery. Proc Natl Acad Sci USA 106:534–539CrossRefPubMed Wu Y, Zheng Z, Jiang Y et al (2009) The specificity of T cell regulation that enables self-nonself discrimination in the periphery. Proc Natl Acad Sci USA 106:534–539CrossRefPubMed
Metadaten
Titel
Lymphocyte subsets in peripheral blood of patients with psoriasis before and after treatment with leishmania antigens
verfasst von
Jose Antonio O’Daly
Beatriz Rodriguez
Tania Ovalles
Civel Pelaez
Publikationsdatum
01.03.2010
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 2/2010
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-009-0992-0

Weitere Artikel der Ausgabe 2/2010

Archives of Dermatological Research 2/2010 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.